TREATMENT WITHDRAWAL AFTER LONG-TERM NUCLEOTIDE ANALOGUE THERAPY WITH OR WITHOUT PEGINTERFERON: PREDICTORS OF ALT FLARES, HBsAg DECLINE AND ACTIVE DISEASE

被引：0

作者：

Feld, Jordan J. ^{[1
]}

Wahed, Abdus ^{[2
]}

Ghany, Marc G. ^{[3
]}

Khalili, Mandana ^{[4
]}

Terrault, Norah ^{[5
]}

Perrillo, Robert P. ^{[6
]}

Di Bisceglie, Adrian M. ^{[7
]}

Fried, Michael W. ^{[8
]}

Belle, Steve ^{[9
]}

Janssen, Harry L. A. ^{[10
]}

Lok, Anna S. ^{[11
,12
]}

机构：

[1] Univ Toronto, Toronto Ctr Liver Dis, Univ Hlth Network, Toronto, ON, Canada

[2] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA

[3] NIDDK, Liver Dis Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA

[4] Univ Calif San Francisco, Gastroenterol & Hepatol, San Francisco, CA 94143 USA

[5] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA

[6] Baylor Univ, Med Ctr, Waco, TX 76798 USA

[7] Hightide Therapeut, Shenzhen, Peoples R China

[8] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA

[9] Univ Pittsburgh, Pittsburgh, PA 15260 USA

[10] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[11] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA

[12] HBRN, Bethesda, MD USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

817

引用

页码：501A / 502A

页数：2